⭐️Remus-engaged in marketing & distributing of finished formulations of pharmaceutical drugs
MainCategories
▶️APIs
▶️Finished Pharmaceutical Formulations
It provides technical consultancy services to various distributors for reports on dossiers of products registered in countries
MainCategories
▶️APIs
▶️Finished Pharmaceutical Formulations
It provides technical consultancy services to various distributors for reports on dossiers of products registered in countries
▶️The company has presence through registered & under registration products in 23 countries like Bhutan,Bolivia,Chile,Costa Rica,Cuba,Dominican Republic,Ecuador,El Salvador, Jamaica, Kuwait, Madagascar, Malaysia,HK, Myanmar,Panama, Trinidad & Tobago, Uzbekistan Venezuela Vietnam
▶️API : It is biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
▶️ Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms
Product Portfolio :
▶️Their product portfolio consists of 429 products. They operate under different brand names across the globe.
▶️It has 295 products registered in total 13 countries and total 134 products are under process of registration in 16 countries
▶️Their product portfolio consists of 429 products. They operate under different brand names across the globe.
▶️It has 295 products registered in total 13 countries and total 134 products are under process of registration in 16 countries
Business plan
▶️B2B supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.
▶️B2B supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.
Competitive Strengths
▶️Experienced Promoters and Management Team
⭐️Wide range of Products
⭐️Strategic Location of Contract Manufacturing Facilities
⭐️Diversified business operations and revenue base
▶️Experienced Promoters and Management Team
⭐️Wide range of Products
⭐️Strategic Location of Contract Manufacturing Facilities
⭐️Diversified business operations and revenue base
Ipo raised to
⭐️To Meet Working Capital Requirements
⭐️Funding investments for acquisitions and general corporate purposes
⭐️To meet Public Issue Expenses
⭐️To Meet Working Capital Requirements
⭐️Funding investments for acquisitions and general corporate purposes
⭐️To meet Public Issue Expenses
Management
▶️ Mr. Arpit Deepakkumar Shah, aged 35 years, is Managing Director and Promoter of the Company. 11 years of experience in the field of sales and operations
He plays vital role in business operations, business development and strategic decisions of the Company.
▶️ Mr. Arpit Deepakkumar Shah, aged 35 years, is Managing Director and Promoter of the Company. 11 years of experience in the field of sales and operations
He plays vital role in business operations, business development and strategic decisions of the Company.
▶️ Mr. Swapnil Jatinbhai Shah, aged 37 years, is Chairman, Whole Time Director & Promoter
▶️With 12 years of experience in the field of finance and business operations.He plays vital role in business operations, business development,financial & strategic decisions of the Co
▶️With 12 years of experience in the field of finance and business operations.He plays vital role in business operations, business development,financial & strategic decisions of the Co
Sales 25cr in Fy 22
Gross Profit 12.45cr
PAT 3.39cr
Comparison with PEERS
Gross Profit 12.45cr
PAT 3.39cr
Comparison with PEERS
🆁🅸🆂🅺🆂
They generated cash of 5cr from operations, 9.28Cr is raised from loans &
4.25cr from issue of shares
So,18 cr is raised
Out of 2 cr went to capex side & 17cr went to purchase of securities
𝙋𝙡𝙚𝙖𝙨𝙚 𝙙o 𝘿𝙪𝙚 𝘿𝙞𝙡𝙞𝙜𝙚𝙣𝙘𝙚 𝙗𝙚𝙛𝙤𝙧𝙚 𝙄𝙣𝙫𝙚𝙨𝙩𝙞𝙣𝙜
They generated cash of 5cr from operations, 9.28Cr is raised from loans &
4.25cr from issue of shares
So,18 cr is raised
Out of 2 cr went to capex side & 17cr went to purchase of securities
𝙋𝙡𝙚𝙖𝙨𝙚 𝙙o 𝘿𝙪𝙚 𝘿𝙞𝙡𝙞𝙜𝙚𝙣𝙘𝙚 𝙗𝙚𝙛𝙤𝙧𝙚 𝙄𝙣𝙫𝙚𝙨𝙩𝙞𝙣𝙜
All info extracted from DRHP
جاري تحميل الاقتراحات...